Log in to save to my catalogue

Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies wi...

Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies wi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_30010404

Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188 Rhenium

About this item

Full title

Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188 Rhenium

Publisher

United States

Journal title

Cancer biotherapy & radiopharmaceuticals, 2018-10, Vol.33 (8), p.349-355

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Radioimmunotherapy offers an effective way to direct ionizing radiation to cancer cells through attachment of radionuclides to antibodies while limiting negative effects of off-target irradiation. This, however, requires effective facile methods for attachment of therapeutic radionuclides onto antibodies. Herein, the authors report their efforts in...

Alternative Titles

Full title

Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188 Rhenium

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_30010404

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_30010404

Other Identifiers

ISSN

1084-9785

E-ISSN

1557-8852

DOI

10.1089/cbr.2018.2480

How to access this item